세계 불임 검사 시장 규모는 2022년 4억 2,695만 달러로 평가되며, 2023년 4억 6,324만 달러에서 2031년 8억 8,970만 달러로 예측 기간(2024-2031년) 동안 8.5%의 CAGR로 성장할 것으로 예상됩니다.
불임 검사 시장은 몇 가지 주요 요인에 힘입어 향후 예측 기간 동안 크게 성장할 것으로 예상됩니다. 특히, 첫 임신을 미루는 추세와 전 세계적으로 불임에 대한 인식이 높아짐에 따라 불임 검사 솔루션에 대한 수요가 증가하고 있습니다. 또한, 전 세계 출산율 감소와 정확도가 높은 혁신적이고 사용자 친화적인 불임 치료 모니터의 도입이 시장 확대의 주요 요인으로 작용하고 있습니다. 특히 선진국에서는 임신과 배란을 동시에 검사할 수 있는 복합 검사 키트의 등장으로 시장 성장을 더욱 촉진할 것으로 예상됩니다. 헬스케어 인프라에 대한 투자 강화도 고급 불임 검사 제품의 보급을 지원하여 소비자들에게 보다 친숙하게 다가갈 수 있도록 돕고 있습니다. 그러나 PCOS/PCOD와 같은 질환을 앓고 있는 여성들에게 소변 기반 배란 모니터링의 신뢰도가 일정하지 않고, 배란 테스트에 드는 비용이 비싸다는 점은 잠재적인 구매 의욕을 떨어뜨릴 수 있는 요인으로 작용할 수 있습니다. 전반적으로 불임 검사 시장은 인구통계학적 추세와 기술 발전으로 인해 유망한 성장 잠재력을 보여주고 있지만, 정확도 문제와 비용 관련 장벽을 해결하는 것이 시장 침투를 극대화하고 필수적인 건강 제품에 대한 소비자 신뢰를 구축하는 데 매우 중요합니다.
Global Fertility Test Market size was valued at USD 426.95 million in 2022 and is poised to grow from USD 463.24 million in 2023 to USD 889.7 million by 2031, growing at a CAGR of 8.5% during the forecast period (2024-2031).
The fertility test market is poised for significant growth in the upcoming forecast period, propelled by several key factors. Notably, the trend of postponing first pregnancies and an increasing global emphasis on fertility awareness are driving demand for fertility testing solutions. Additionally, declining fertility rates worldwide, combined with the introduction of innovative, user-friendly fertility monitors that boast high accuracy, are key contributors to the market's expansion. The rise of combined testing kits that address both pregnancy and ovulation-particularly in developed countries-is expected to further stimulate market growth. Enhanced healthcare infrastructure investments are also supporting the proliferation of advanced fertility testing products, making them more accessible to consumers. However, challenges remain, including the inconsistent reliability of urine-based ovulation monitors for women with conditions such as PCOS/PCOD, as well as the high costs associated with acquiring these tests, which may deter potential buyers. Overall, while the fertility test market shows promising growth potential driven by demographic trends and technological advancements, addressing accuracy concerns and cost-related barriers will be crucial for maximizing market penetration and fostering consumer trust in these essential health products.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Fertility Test market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Fertility Test Market Segmental Analysis
Global Fertility Test Market is segmented by Product, Mode of Purchase, Application, End User and region. Based on Product, the market is segmented into Ovulation Predictor Kits, Fertility Monitors (Urine, Saliva, Blood), Male Fertility Testing Products. Based on Mode of Purchase, the market is segmented into OTC based products, Prescription based products, Online products. Based on application, the market is segmented into Female Fertility Products, Male Fertility Products. Based on end user, the market is segmented into home care, Fertility clinics, hospitals, others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.
Driver of the Global Fertility Test Market
The Global Fertility Test market is significantly influenced by the increasing focus on reproductive health, particularly highlighted by the changing demographics of first-time pregnancies. There has been a noteworthy rise in the average age at which women are having their first child, with many women now waiting until 30 or older, as reported by the OECD. This trend has emerged due to a decline in teenage births and reflects a growing preference among women to postpone parenthood. Consequently, the heightened occurrence of first pregnancies among older women is driving demand for fertility-related products and services, propelling the expansion of the market.
Restraints in the Global Fertility Test Market
One significant restraint in the Global Fertility Test market is the limited precision of ovulation prediction kits. These kits function by measuring increases in luteinizing hormone (LH) levels, which typically spike 24-36 hours before ovulation. However, they fall short in reliably confirming ovulation in certain conditions, such as luteinized unruptured follicle syndrome, where the egg remains with the follicle post-LH surge. Additionally, these kits only indicate the onset of ovulation rather than pinpointing the exact timing or accounting for anovulation. The reliance solely on LH detection means they overlook other important markers like fertile cervical mucus, potentially hindering market growth due to their limited accuracy.
Market Trends of the Global Fertility Test Market
The Global Fertility Test market is witnessing a notable trend characterized by the rapid integration of digital health technologies, particularly through the use of smartphones and wearable devices. Fertility tracking apps and advanced ovulation monitors are enabling consumers to monitor their menstrual cycles and fertility metrics with unprecedented convenience. This shift toward digital solutions is transforming traditional fertility testing methodologies, offering users real-time data and personalized insights that foster proactive family planning. As individuals seek more accessible and informed approaches to reproductive health, this trend is likely to drive significant growth in the fertility test market, enhancing user engagement and confidence in their fertility journeys.